SELL (30% trim at lower end of range, stop at $211.16, no short reloads)

• Technical bearish setup is real but stock is only $4.80 above lower Bollinger Band at $192.02 with RSI at 34 and ATR compressed to $4.69—reducing exposure is warranted but emptying the position is not
• Dividend is protected by 1.7x FCF coverage ($4.62B TTM FCF vs $2.69B dividend obligations) and investment-grade balance sheet ($3.17B cash, 2.7x net debt/EBITDA)
• Even a severe 30% OCF decline scenario still generates ~$6.5B against current dividend obligations—dividend cut is a tail scenario, not base case
• Forward P/E of 16.8x at $11.73 EPS on a 7.35% net margin, 12.5% ROA company at a cyclical bottom is not a value trap
• 0.85 beta and 2.54% dividend yield provide genuine defensive characteristics for a cyclically-pressured but not structurally-deteriorating business
• Proposed trim should be 30% (lower end), not 50%, to preserve 70% optionality for re-entry or continued holding
• Stop at $211.16 should not be tightened—counter-trend rallies of 5-7% are routine and premature stop-out destroys capital
• No short reloads into bounces at $200-205—coiled spring setups fire in the direction of catalyst, not always trend
• Wait for confirmed breakdown below $192.02 for defined-risk short addition, or reversion above 50 SMA at $211.16 to maintain remaining long with confidence

→ vs aggressive: Short reloads at $200-205 create asymmetric tail risk—if LOW bases at lower band, prints higher RSI low, and mean-reverts toward 10 EMA at $201.59 or 20 SMA at $208.19, shorts get squeezed with 1-2 ATR ($4.69-$9.38) of pain

→ vs aggressive: Dividend cut scenario is constructing a catastrophic narrative and treating probability as meaningfully elevated when $4.62B FCF and 1.7x coverage make it a tail scenario, not base case

→ vs aggressive: The view is 'sell because it might get cheaper'—which produces the worst outcomes for clients who miss the reversion; value traps require structural deterioration, not cyclical pressure

→ vs aggressive: 30-50% trim toward upper end is maximum conviction selling dressed as risk management—conservative view is reduce at measured pace, preserve optionality, avoid selling into capitulation and buying back higher

→ vs aggressive: Bearish catalysts (macro factors, elevated rates) are largely priced into a stock that has already corrected 26% in twelve months and is hugging 52-week low

SELL 35-40% of position; stop at $201.59 (10 EMA); deploy proceeds 50% to short-duration Treasuries at 5% yield, 50% cash reserve for tactical redeployment on confirmed triggers

• Price below all three major moving averages; MACD accelerating negative with histogram at negative 1.30; RSI making lower lows with no divergence; VWMA confirming volume-weighted distribution
• Trim 35-40% of full-size position reflects genuine middle of proposed 30-50% range, balancing tactical risk reduction with strategic participation
• Stop placement at 10 EMA ($201.59) more appropriate than 50 SMA ($211.16) in accelerating downtrend; 50 SMA will be hit by routine counter-trend mean-reversion within bear trends
• Dividend cut is tail risk, not base case: $4.62B trailing FCF against $2.69B dividends provides 1.7x coverage (Q2 FY26 high-water-mark); normalized coverage closer to 1.3-1.4x including $709M seasonal inventory drawdown
• Residual 60-65% position held as 12-18 month strategic cyclical allocation with clear re-entry framework
• Redeployment triggers: (1) confirmed daily close below $192.02 with volume to add short exposure, or (2) reversion pattern with price above $208 (20 SMA), rising volume, and RSI higher low to add long exposure
• Key macro catalysts to monitor: 10-year Treasury yield, MBA mortgage applications index, next CPI print, October Fed meeting, September existing-home sales release
• Short reload at $200-205 creates asymmetric squeeze risk given LOW is $4.80 above major support at $192.02; potential ATR pain of $4.69-$9.38 per share on bounce

→ vs aggressive: Directional conviction on coiled spring is unsupported—ATR compression means volatility expansion is coming but direction is unknown; treating unknown as known is not risk management

→ vs aggressive: Short reload at $200-205 creates asymmetric squeeze risk given $4.80 proximity to support at $192.02; ATR pain of $4.69-$9.38 per share against already-trimmed position is poor risk-reward

→ vs aggressive: Dividend cut framed as base case when math indicates tail scenario—even 30% operating cash flow decline still leaves $6.5B operating cash flow against $2.69B dividend

→ vs conservative: 30% trim understates cyclical duration risk—holding 70% through 12-18 months of zero Fed cuts, 10-year above 5%, and rising recession odds is significant concentration risk

→ vs conservative: FCF coverage of 1.7x is Q2 FY26 high-water-mark including $709M seasonal inventory drawdown; normalized coverage of 1.3-1.4x still comfortable but not bulletproof—presenting peak number as steady-state is misleading

→ vs conservative: Stop at 50 SMA ($211.16) will get hit on routine counter-trend action in accelerating downtrend; using outdated resistance reference as stop level anchoring, not adaptive risk management